smallest detail. RESIST consists of six partner institutions. The spokesperson is Professor Dr Thomas Schulz, head of the MHH Institute of Virology. RESIST is funded by the German Research Foundation (DFG)
Gastroenterology, OE 6810, Left program in December 2015! Rishikesh Lotke INDIA supervisor: Prof. Dr. Schulz, Virology, OE 5230, project: Does the latent replication of gammaherpesviral genomes occur in a
Protein profile of breast cancer Final exam November 2005 Linding Wang CHINA supervisor: Prof. Dr. Schulz, Virology, project: Transposon and targeted mutagenesis of a recombinant KSHV genome to identify
Kleine-Weber H, Hoffmann M, Cossmann A, Yilmaz M, Pink I, Hoeper MM, Behrens GMN, Pöhlmann S, Blasczyk R, Schulz TF, Förster R. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19
pulmonary inflammation Final exam June 2012 Kiran Peddireddi (nee Bala) INDIA supervisor: Prof. Dr Schulz, Virology, OE 5230, project: Development of an animal model to test the in-vivo function of the Kaposi
Cardiovasc Med. 2022;9:899583. https://pubmed.ncbi.nlm.nih.gov/35711345/ . Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: Path [...] cardiomyocytes. Mol Ther. 2022. https://pubmed.ncbi.nlm.nih.gov/35810332/. Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: Path [...] Meer P, Passier R, Perbellini F, Perrino C, Pesce M, Priori S, Remme CA, Rosenhahn B, Schotten U, Schulz R, Sipido KR, Sluijter JPG, van Steenbeek F, Steffens S, Terracciano CM, Tocchetti CG, Vlasman P
TRAF2. Cell Death Dis. 14(7):480. doi: 10.1038/s41419-023-06014-5 * equal contribution Schlüter D, E. Schulz-Niemand, M. Stein, M. Naumann (2022) Ovarian tumor domain proteases in pathogen infection. Trends
Jacobs, and R.E. Schmidt. 1997. Katecholamine und Immunfunktionen. In Psychoneuroimmunologie. K.H. Schulz, J. Kugler, and M. Schedlowski, editors. Huber-Verlag, Göttingen. 243–256. Jacobs, R. 1996. Methoden
Sep;1849(9):1145-54. 9. Vogt C, Hackmann C, Rabner A, Koste L, Santag S, Kati S, Mandel-Gutfreund Y, Schulz TF, Bohne J. ORF57 overcomes the detrimental sequence bias of Kaposi’s sarcoma-associated herpesvirus
Thomas Krey Prof. Dr. Martin Messerle Dr. Nora Schmidt Prof. Dr. Sabrina Schreiner Prof. Dr. Thomas Schulz Prof. Dr. Beate Sodeik Prof. Dr. Abel Viejo-Borbolla Institute of Immunology PD Dr. Berislav Bošnjak